NCT06004830View on ClinicalTrials.gov

Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 1

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 6, 2023

Primary Completion Date

October 1, 2025

Study Completion Date

January 1, 2026

Conditions
Alcohol Use DisorderHiv
Interventions
DRUG

Spironolactone

All participants will receive a prescription for spironolactone and will meet with a clinical pharmacist and addiction psychiatrist for further support

Trial Locations (1)

30033

RECRUITING

Atlanta VA Medical Center, Decatur

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Yale University

OTHER